Measuring C-reactive protein alongside lipid levels improves the identification of women at risk for cardiovascular events.
Does the addition of C-reactive protein measurement to lipid screening improve the prediction of cardiovascular events in women?
Adding C-reactive protein measurement to standard lipid screening may improve cardiovascular risk prediction in women.
The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.
“A common teaching in cardiology holds that inflammation plays a causal role in atherosclerotic cardiovascular disease (ASCVD). The recent announcement that the ZEUS cardiovascular outcomes trial of the anti-inflammatory drug ziltivekimab returned null results has seriously challenged this.”
Ridker et al. (2000) studied this question. Measuring C-reactive protein alongside lipid levels improves the identification of women at risk for cardiovascular events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: